Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: results from a randomized clinical trial.

Diaz RS, Shytaj IL, Giron LB, Obermaier B, Libera ED Jr, Galinskas J, Dias D, Hunter J, Janini M, Gosuen G, Ferreira PA, Sucupira MC, Maricato J, Fackler O, Lusic M, Savarino A; SPARC working group.

Int J Antimicrob Agents. 2019 Aug 5. pii: S0924-8579(19)30212-2. doi: 10.1016/j.ijantimicag.2019.08.001. [Epub ahead of print]

PMID:
31394172
2.

Simultaneous Quantitative Detection of Six Families of Antibiotics in Honey Using A Biochip Multi-Array Technology.

Barrasso R, Bonerba E, Savarino AE, Ceci E, Bozzo G, Tantillo G.

Vet Sci. 2018 Dec 28;6(1). pii: E1. doi: 10.3390/vetsci6010001.

3.

Mode of Surgical Injury Influences the Source of Urothelial Progenitors during Bladder Defect Repair.

Schäfer FM, Algarrahi K, Savarino A, Yang X, Seager C, Franck D, Costa K, Liu S, Logvinenko T, Adam R, Mauney JR.

Stem Cell Reports. 2017 Dec 12;9(6):2005-2017. doi: 10.1016/j.stemcr.2017.10.025. Epub 2017 Nov 22.

4.

Bilayer silk fibroin grafts support functional oesophageal repair in a rodent model of caustic injury.

Algarrahi K, Franck D, Savarino A, Cristofaro V, Yang X, Affas S, Schäfer FM, Sullivan MP, Estrada CR Jr, Mauney JR.

J Tissue Eng Regen Med. 2018 Feb;12(2):e1068-e1075. doi: 10.1002/term.2434. Epub 2017 Jun 21.

5.

Bi-layer silk fibroin grafts support functional tissue regeneration in a porcine model of onlay esophagoplasty.

Algarrahi K, Franck D, Cristofaro V, Yang X, Savarino A, Affas S, Schäfer FM, Ghezzi C, Jennings R, Nedder A, Kaplan DL, Sullivan MP, Estrada CR Jr, Mauney JR.

J Tissue Eng Regen Med. 2018 Feb;12(2):e894-e904. doi: 10.1002/term.2402. Epub 2017 Jun 20.

6.

Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models.

Delvecchio R, Higa LM, Pezzuto P, Valadão AL, Garcez PP, Monteiro FL, Loiola EC, Dias AA, Silva FJ, Aliota MT, Caine EA, Osorio JE, Bellio M, O'Connor DH, Rehen S, de Aguiar RS, Savarino A, Campanati L, Tanuri A.

Viruses. 2016 Nov 29;8(12). pii: E322.

7.

Dual targeting of the thioredoxin and glutathione systems in cancer and HIV.

Benhar M, Shytaj IL, Stamler JS, Savarino A.

J Clin Invest. 2016 May 2;126(5):1630-9. doi: 10.1172/JCI85339. Epub 2016 May 2. Review.

8.

Lysine-specific demethylase-1 (LSD1) is compartmentalized at nuclear chromocenters in early post-mitotic cells of the olfactory sensory neuronal lineage.

Kilinc S, Savarino A, Coleman JH, Schwob JE, Lane RP.

Mol Cell Neurosci. 2016 Jul;74:58-70. doi: 10.1016/j.mcn.2016.03.001. Epub 2016 Mar 4.

9.

Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS.

Savarino A, Shytaj IL.

Retrovirology. 2015 Jun 18;12:51. doi: 10.1186/s12977-015-0178-0. Review.

10.

Cell-mediated anti-Gag immunity in pharmacologically induced functional cure of simian AIDS: a 'bottleneck effect'?

Shytaj IL, Savarino A.

J Med Primatol. 2015 Oct;44(5):227-40. doi: 10.1111/jmp.12176. Epub 2015 Jun 8.

PMID:
26058990
11.

Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection.

Shytaj IL, Nickel G, Arts E, Farrell N, Biffoni M, Pal R, Chung HK, LaBranche C, Montefiori D, Vargas-Inchaustegui D, Robert-Guroff M, Lewis MG, Sacha JB, Palamara AT, Savarino A.

J Virol. 2015 Aug;89(15):7521-35. doi: 10.1128/JVI.00396-15. Epub 2015 May 13.

12.

A candidate anti-HIV reservoir compound, auranofin, exerts a selective 'anti-memory' effect by exploiting the baseline oxidative status of lymphocytes.

Chirullo B, Sgarbanti R, Limongi D, Shytaj IL, Alvarez D, Das B, Boe A, DaFonseca S, Chomont N, Liotta L, Petricoin EI, Norelli S, Pelosi E, Garaci E, Savarino A, Palamara AT.

Cell Death Dis. 2013 Dec 5;4:e944. doi: 10.1038/cddis.2013.473.

13.

A cure for AIDS: a matter of timing?

Shytaj IL, Savarino A.

Retrovirology. 2013 Nov 22;10:145. doi: 10.1186/1742-4690-10-145. Review.

14.

Investigational treatment suspension and enhanced cell-mediated immunity at rebound followed by drug-free remission of simian AIDS.

Shytaj IL, Chirullo B, Wagner W, Ferrari MG, Sgarbanti R, Corte AD, LaBranche C, Lopalco L, Palamara AT, Montefiori D, Lewis MG, Garaci E, Savarino A.

Retrovirology. 2013 Jul 16;10:71. doi: 10.1186/1742-4690-10-71.

15.

Therapeutic imprinting of the immune system: towards a remission of AIDS in primates?

Savarino A, Garaci E.

Retrovirology. 2012 Sep 14;9:75. doi: 10.1186/1742-4690-9-75.

16.

A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model.

Shytaj IL, Norelli S, Chirullo B, Della Corte A, Collins M, Yalley-Ogunro J, Greenhouse J, Iraci N, Acosta EP, Barreca ML, Lewis MG, Savarino A.

PLoS Pathog. 2012;8(6):e1002774. doi: 10.1371/journal.ppat.1002774. Epub 2012 Jun 21.

17.

Use of chloroquine in viral diseases.

Savarino A.

Lancet Infect Dis. 2011 Sep;11(9):653-4. doi: 10.1016/S1473-3099(11)70092-5. Epub 2011 May 5. No abstract available.

PMID:
21550312
18.

Gold drug auranofin restricts the viral reservoir in the monkey AIDS model and induces containment of viral load following ART suspension.

Lewis MG, DaFonseca S, Chomont N, Palamara AT, Tardugno M, Mai A, Collins M, Wagner WL, Yalley-Ogunro J, Greenhouse J, Chirullo B, Norelli S, Garaci E, Savarino A.

AIDS. 2011 Jul 17;25(11):1347-56. doi: 10.1097/QAD.0b013e328347bd77.

PMID:
21505294
19.

Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA).

Banna GL, Di Maio M, Follador A, Collovà E, Menis J, Novello S, Bria E; ISA Co-Authors, Airoldi M, Amoroso D, Ardizzoia A, Aurilio G, Bajetta E, Ballardini P, Barbieri F, Barletta E, Balzelloni ML, Basso U, Bernardini I, Boni C, Bordin V, Bretti S, Bronte G, Brunetti C, Buti S, Capanna L, Colombo A, Condemi G, Cortinovis D, Dambrosio M, Di Fonzo C, Di Lucca G, Dima G, Falzetta A, Favaretto A, Ferraù F, Garetto L, Gebbia V, Genestreti G, Gentile AL, Giovanardi F, Labianca R, Lorusso V, Mantovani G, Martelli O, Massari F, Mazzoli M, Michetti G, Mordenti P, Mucciarini C, Munao S, Nacci A, Pogliani C, Procopio G, Riccardi F, Rizzato S, Rossi A, Rosti G, Russo P, Saladino T, Salesi N, Santangelo D, Sava T, Savarino A, Spinnato F, Tiseo M, Tomassi O, Tondulli L, Tonini G, Turano S, Valerio MR, Verderame F, Zanelli F, Zanon E.

Lung Cancer. 2011 Jul;73(1):78-88. doi: 10.1016/j.lungcan.2010.10.020. Epub 2010 Dec 8.

PMID:
21144614
20.

Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy.

Lewis MG, Norelli S, Collins M, Barreca ML, Iraci N, Chirullo B, Yalley-Ogunro J, Greenhouse J, Titti F, Garaci E, Savarino A.

Retrovirology. 2010 Mar 16;7:21. doi: 10.1186/1742-4690-7-21.

21.

Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria.

Spaccapelo R, Janse CJ, Caterbi S, Franke-Fayard B, Bonilla JA, Syphard LM, Di Cristina M, Dottorini T, Savarino A, Cassone A, Bistoni F, Waters AP, Dame JB, Crisanti A.

Am J Pathol. 2010 Jan;176(1):205-17. doi: 10.2353/ajpath.2010.090504. Epub 2009 Dec 17.

22.

"Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence.

Savarino A, Mai A, Norelli S, El Daker S, Valente S, Rotili D, Altucci L, Palamara AT, Garaci E.

Retrovirology. 2009 Jun 2;6:52. doi: 10.1186/1742-4690-6-52.

23.

Protective effects of L- and D-carnosine on alpha-crystallin amyloid fibril formation: implications for cataract disease.

Attanasio F, Cataldo S, Fisichella S, Nicoletti S, Nicoletti VG, Pignataro B, Savarino A, Rizzarelli E.

Biochemistry. 2009 Jul 14;48(27):6522-31. doi: 10.1021/bi900343n.

PMID:
19441807
24.

Characterization of the serological response to phospholipase D protein of Chlamydophila pneumoniae in patients with acute coronary syndromes.

Mancini F, Savarino A, Losardo M, Cassone A, Ciervo A.

Microbes Infect. 2009 Mar;11(3):367-73. doi: 10.1016/j.micinf.2008.12.015. Epub 2009 Jan 31.

PMID:
19397877
25.

Non-cancer uses of histone deacetylase inhibitors: effects on infectious diseases and beta-hemoglobinopathies.

Rotili D, Simonetti G, Savarino A, Palamara AT, Migliaccio AR, Mai A.

Curr Top Med Chem. 2009;9(3):272-91. Review.

PMID:
19355991
26.

Evaluation of the antiretroviral effects of a PEG-conjugated peptide derived from human CD38.

Bensi T, Mele F, Ferretti M, Norelli S, El Daker S, Chiocchetti A, Maria Rojo J, Cauda R, Dianzani U, Savarino A.

Expert Opin Ther Targets. 2009 Feb;13(2):141-52. doi: 10.1517/14728220802637147 .

PMID:
19236233
27.

Use of the BacT/Alert MB mycobacterial blood culture system for detection of mycobacteria in sterile body fluids other than blood.

Mattei R, Savarino A, Fabbri M, Moneta S, Tortoli E.

J Clin Microbiol. 2009 Mar;47(3):711-4. doi: 10.1128/JCM.01712-08. Epub 2008 Dec 24.

28.

Response of feline immunodeficiency virus (FIV) to tipranavir may provide new clues for development of broad-based inhibitors of retroviral proteases acting on drug-resistant HIV-1.

Norelli S, El Daker S, D'Ostilio D, Mele F, Mancini F, Taglia F, Ruggieri A, Ciccozzi M, Cauda R, Ciervo A, Barreca ML, Pistello M, Bendinelli M, Savarino A.

Curr HIV Res. 2008 Jun;6(4):306-17.

PMID:
18691029
29.
30.

Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS.

Savarino A, Pistello M, D'Ostilio D, Zabogli E, Taglia F, Mancini F, Ferro S, Matteucci D, De Luca L, Barreca ML, Ciervo A, Chimirri A, Ciccozzi M, Bendinelli M.

Retrovirology. 2007 Oct 30;4:79.

31.

On the use of chloroquine for chikungunya.

Savarino A, Cauda R, Cassone A.

Lancet Infect Dis. 2007 Oct;7(10):633. No abstract available.

PMID:
17897603
32.

Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.

Zuccotti G, Amendola A, Viganò A, Pariani E, Zappa A, Pogliani L, Giacomet V, Savarino A, Podestà A, Rottoli A, Tanzi E, Zanetti A, Radaelli G.

Vaccine. 2007 Sep 17;25(37-38):6692-8. Epub 2007 Jul 27.

PMID:
17697730
33.

Different pH requirements are associated with divergent inhibitory effects of chloroquine on human and avian influenza A viruses.

Di Trani L, Savarino A, Campitelli L, Norelli S, Puzelli S, D'Ostilio D, Vignolo E, Donatelli I, Cassone A.

Virol J. 2007 May 3;4:39.

35.

Trehalose effects on alpha-crystallin aggregates.

Attanasio F, Cascio C, Fisichella S, Nicoletti VG, Pignataro B, Savarino A, Rizzarelli E.

Biochem Biophys Res Commun. 2007 Mar 23;354(4):899-905. Epub 2007 Jan 22.

PMID:
17266925
36.

A historical sketch of the discovery and development of HIV-1 integrase inhibitors.

Savarino A.

Expert Opin Investig Drugs. 2006 Dec;15(12):1507-22.

PMID:
17107277
37.

Risks and benefits of chloroquine use in anticancer strategies.

Savarino A, Lucia MB, Giordano F, Cauda R.

Lancet Oncol. 2006 Oct;7(10):792-3. No abstract available.

PMID:
17012039
38.

New insights into the antiviral effects of chloroquine.

Savarino A, Di Trani L, Donatelli I, Cauda R, Cassone A.

Lancet Infect Dis. 2006 Feb;6(2):67-9. No abstract available.

PMID:
16439323
39.

[Severe combined immunodeficiencies: a case of adenosine-deaminase deficit].

Macellaro P, Savarino A, Cucchi G, Lazzati A, Zuccotti GV.

Pediatr Med Chir. 2004 May-Jun;26(3):191-5. Italian.

PMID:
16366403
40.

Role of lymphocyte multidrug resistance protein 1 in HIV infection: expression, function, and consequences of inhibition.

Lucia MB, Savarino A, Straface E, Golotta C, Rastrelli E, Matarrese P, Rutella S, Malorni W, Cauda R.

J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):257-66.

PMID:
16249698
41.

Atazanavir inhibits P-glycoprotein and multidrug resistance-associated protein efflux activity.

Lucia MB, Golotta C, Rutella S, Rastrelli E, Savarino A, Cauda R.

J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):635-7. No abstract available.

PMID:
16044020
42.

Proteomics of gluten: mapping of the 1Bx7 glutenin subunit in Chinese Spring cultivar by matrix-assisted laser desorption/ionization.

Alberghina G, Cozzolino R, Fisichella S, Garozzo D, Savarino A.

Rapid Commun Mass Spectrom. 2005;19(14):2069-74.

PMID:
15988718
43.

High-performance liquid chromatographic separation and chiroptical properties of the enantiomers of naringenin and other flavanones.

Caccamese S, Caruso C, Parrinello N, Savarino A.

J Chromatogr A. 2005 May 27;1076(1-2):155-62.

PMID:
15974082
45.

Aspartic proteases of Plasmodium falciparum as the target of HIV-1 protease inhibitors.

Savarino A, Cauda R, Cassone A.

J Infect Dis. 2005 Apr 15;191(8):1381-2; author reply 1382-3. No abstract available.

PMID:
15776390
46.

Structural studies of wheat flour glutenin polymers by CD spectroscopy.

Fisichella S, Amato ME, Lafiandra D, Mantarro D, Palermo A, Savarino A, Scarlata G.

Biopolymers. 2004 Jul;74(4):287-301.

PMID:
15211498
47.

Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors.

Savarino A, Lucia MB, Rastrelli E, Rutella S, Golotta C, Morra E, Tamburrini E, Perno CF, Boelaert JR, Sperber K, Cauda R.

J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):223-32.

PMID:
15076236
48.

Role of FAS in HIV infection.

Dianzani U, Bensi T, Savarino A, Sametti S, Indelicato M, Mesturini R, Chiocchetti A.

Curr HIV Res. 2003 Oct;1(4):405-17. Review.

PMID:
15049427
49.

Effects of chloroquine on viral infections: an old drug against today's diseases?

Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R.

Lancet Infect Dis. 2003 Nov;3(11):722-7. Review.

PMID:
14592603
50.

Human CD38 interferes with HIV-1 fusion through a sequence homologous to the V3 loop of the viral envelope glycoprotein gp120.

Savarino A, Bensi T, Chiocchetti A, Bottarel F, Mesturini R, Ferrero E, Calosso L, Deaglio S, Ortolan E, Buttò S, Cafaro A, Katada T, Ensoli B, Malavasi F, Dianzani U.

FASEB J. 2003 Mar;17(3):461-3. Epub 2003 Jan 22.

PMID:
12551845

Supplemental Content

Loading ...
Support Center